Taixing People's Hospital
🇨🇳China
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 4
1 (50.0%)A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Taixing People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06328049
- Locations
- 🇨🇳
Taixing People's Hospital, Taixing, Jiangsu, China
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
Phase 4
- Conditions
- Chronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2
- Interventions
- Drug: placebo
- First Posted Date
- 2012-03-22
- Last Posted Date
- 2015-06-08
- Lead Sponsor
- Taixing People's Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT01561222
- Locations
- 🇨🇳
Taixing People's Hospital, Taixing, Jiangsu, China
News
No news found